Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis

Published:2013-09-17 Issue:3 Volume:170 Page:602-613
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

González-García C¹,Bravo B¹,Ballester A¹,Gómez-Pérez R¹,Eguiluz C²,Redondo M³,Martínez A³,Gil C³,Ballester S¹

Affiliation:

1. Unidad de Regulación Génica; UFIEC; Instituto de Salud Carlos III; Madrid; Spain

2. Unidad de Veterinaria; CNM; Instituto de Salud Carlos III; Madrid; Spain

3. Instituto de Química Médica; Consejo Superior de Investigaciones Científicas; Madrid; Spain

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12308/fullpdf

Reference53 articles.

1. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis;Axtell;Nat Med,2010

2. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells;Batten;Nat Immunol,2006

3. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice;Bettelli;J Immunol,1998

4. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis;Bettelli;J Autoimmun,2003

5. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells;Bettelli;Nature,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

2. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review;Molecular Biology Reports;2024-04-15

3. The β2-adrenergic receptor agonist terbutaline upregulates T helper-17 cells in a protein kinase A-dependent manner;Human Immunology;2023-10

4. Phosphodiesterase 7 as a therapeutic target – Where are we now?;Cellular Signalling;2023-08

5. Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury;International Journal of Molecular Sciences;2023-05-02